WEEKLY ADMINISTRATION OF PACLITAXEL IN HORMONE-REFRACTORY PROSTATE CANCER PATIENTS

被引：0
|
作者：
Lombardo, Laura [1 ]
Mucciarini, Claudia [1 ]
Castagnetti, Giovanni [1 ]
Nicolini, Massimiliano [1 ]
Maur, Michela [1 ]
Frassoldati, Antonio [1 ]
Conte, Pier Franco [1 ]
机构：
[1] Univ Modena & Reggio Emilia, Div Med Oncol, Modena, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] Chemotherapy in hormone-refractory prostate cancer
    Biedermann, B
    Pless, M
    Herrmann, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (28-29) : 874 - 879
  • [42] Update on hormone-refractory prostate cancer
    Kasamon, KM
    Dawson, NA
    CURRENT OPINION IN UROLOGY, 2004, 14 (03) : 185 - 193
  • [43] Chemotherapy in hormone-refractory prostate cancer
    Wolff, Johannes Maria
    CONTROVERSIES IN THE TREATMENT OF PROSTATE CANCER, 2008, 41 : 103 - 107
  • [44] A phase I study of estramustine, weekly docetaxel, and carboplatin chemotherapy in patients with hormone-refractory prostate cancer
    Oh, WK
    Hagmann, E
    Manola, J
    George, DJ
    Gilligan, TD
    Jacobson, JO
    Smith, MR
    Kaufman, DS
    Kantoff, PW
    CLINICAL CANCER RESEARCH, 2005, 11 (01) : 284 - 289
  • [45] A Phase IIa trial of weekly EP0906 in patients with hormone-refractory prostate cancer (HPRC).
    Hussain, A
    Dipaola, RS
    Baron, AD
    Higano, CS
    Tchekmediyan, NS
    Miller, JA
    Rothermel, JD
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 397S - 397S
  • [46] Weekly Administration of Docetaxel and Epirubicin as First-Line Treatment for Hormone-Refractory Prostate Carcinoma
    Neri, B.
    Molinara, E.
    Pantaleo, P.
    Rangan, S.
    Crisci, A.
    Della Melina, A.
    Raugei, A.
    Villari, D.
    Nicita, G.
    ONCOLOGY RESEARCH, 2009, 17 (11-12) : 565 - 570
  • [47] Increase of circulating chromogranin a in patients with hormone-refractory prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 94 - 94
  • [48] New hope for patients with metastatic hormone-refractory prostate cancer
    de Wit, Ronald
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (15) : 817 - 823
  • [49] Pilot study of rapamycin in patients with hormone-refractory prostate cancer
    Amato, Robert J.
    Jac, Jaroslaw
    Mohammad, Taqi
    Saxena, Somya
    CLINICAL GENITOURINARY CANCER, 2008, 6 (02) : 97 - 102
  • [50] Radiotherapy for local progression in patients with hormone-refractory prostate cancer
    Furuya, Y
    Akakura, K
    Akimoto, S
    Ichikawa, T
    Ito, H
    INTERNATIONAL JOURNAL OF UROLOGY, 1999, 6 (04) : 187 - 191
12345